Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis

BACKGROUND: Intravenous thrombolysis using recombinant tissue plasminogen activator remains the mainstay treatment of acute ischemic stroke (AIS), although endovascular treatment is becoming standard of care in case of large vessel occlusions (LVO). To quantify the thrombus burden in LVO, a semiquan...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Szegedi, István, Orbán-Kálmándi, Rita, Nagy, Attila, Sarkady, Ferenc, Vasas, Nikolett, Sik, Máté, Lánczi, Levente István, Berényi, Ervin, Oláh, László, Crișan, Alexandra, Csiba, László, Bagoly, Zsuzsa
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8263307/
https://ncbi.nlm.nih.gov/pubmed/34234378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0254253
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars